EM1806I "Chronic Thromboembolic Pulmonary Hypertension – An Update for 2018" (IM GR-062918)
The purpose of this session is to review the history of our understanding of CTEPH and its pathophysiology and natural history. The diagnostic evaluation of a patient with suspected CTEPH will be reviewed as will current concepts in the surgical, interventional and medical treatment of the disease.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Define CTEPH and describe its natural history.
- Review the diagnostic evaluation of a patient with suspected CTEPH.
- Describe the approach to intervention or medical therapy for CTEPH.
Sonja Bartolome, M.D.
Associate Professor of Internal Medicine
Medical Director, Chronic Thromboembolic Pulmonary Hypertension Program
Associate Director, Pulmonary Hypertension Program
Division of Pulmonary & Critical Care Medicine
Dr. Bartolome is a clinician-educator in the division of Pulmonary and Critical Care Medicine and a subspecialist in pulmonary arterial hypertension and pulmonary vascular disease. She participates in multiple clinical trials regarding these rare diseases, is published in these areas, and lectures on these subjects both around the United States and internationally. She is a member of the International CTEPH association, a member of the CTEPH working group and the Scientific Leadership Council for the Pulmonary Hypertension Association and a member of the CTEPH council of the International Society for Heart and Lung Transplantation. She is also the medical director of UT Southwestern’s new Chronic Thromboembolic Pulmonary Hypertension Program.
- 1.00 AMA